Scorpius Holdings
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SCPX and buy or sell other stocks, ETFs, and their options commission-free!About SCPX
Scorpius Holdings, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness.
CEOJeff A. Wolf, MBA
CEOJeff A. Wolf, MBA
Employees84
Employees84
HeadquartersMorrisville, North Carolina
HeadquartersMorrisville, North Carolina
Founded2008
Founded2008
Employees84
Employees84
SCPX Key Statistics
Market cap846.75
Market cap846.75
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume13.08K
Average volume13.08K
High today$0.0047
High today$0.0047
Low today$0.0001
Low today$0.0001
Open price$0.0001
Open price$0.0001
Volume60.97K
Volume60.97K
52 Week high$146.00
52 Week high$146.00
52 Week low$0.0001
52 Week low$0.0001
Stock Snapshot
The current Scorpius Holdings(SCPX) stock price is $0.00, with a market capitalization of 846.75. The stock trades at a price-to-earnings (P/E) ratio of -0.02.
On 2025-12-07, Scorpius Holdings(SCPX) stock moved within a range of $0.00 to $0.00. With shares now at $0.00, the stock is trading +4600.0% above its intraday low and 0.0% below the session's peak.
Trading volume for Scorpius Holdings(SCPX) stock has reached 60.97K, versus its average volume of 13.08K.
The stock's 52-week range extends from a low of $0.00 to a high of $146.00.
The stock's 52-week range extends from a low of $0.00 to a high of $146.00.
People also own
Based on the portfolios of people who own SCPX. This list is generated using Robinhood data, and it’s not a recommendation.